Financhill
Buy
58

CCLD Quote, Financials, Valuation and Earnings

Last price:
$3.20
Seasonality move :
-7.77%
Day range:
$3.18 - $3.24
52-week range:
$1.14 - $4.75
Dividend yield:
0%
P/E ratio:
78.87x
P/S ratio:
0.88x
P/B ratio:
2.35x
Volume:
200.2K
Avg. volume:
345K
1-year change:
-8.02%
Market cap:
$136.1M
Revenue:
$110.8M
EPS (TTM):
$0.04

Analysts' Opinion

  • Consensus Rating
    CareCloud, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $6.31, CareCloud, Inc. has an estimated upside of 96.65% from its current price of $3.21.
  • Price Target Downside
    According to analysts, the lowest downside price target is $3.25 representing 100% downside risk from its current price of $3.21.

Fair Value

  • According to the consensus of 2 analysts, CareCloud, Inc. has 96.65% upside to fair value with a price target of $6.31 per share.

CCLD vs. S&P 500

  • Over the past 5 trading days, CareCloud, Inc. has underperformed the S&P 500 by -2.53% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • CareCloud, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • CareCloud, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter CareCloud, Inc. reported revenues of $31.1M.

Earnings Growth

  • CareCloud, Inc. has grown year-over-year earnings for 7 quarters straight. In the most recent quarter CareCloud, Inc. reported earnings per share of $0.04.
Enterprise value:
140.7M
EV / Invested capital:
--
Price / LTM sales:
0.88x
EV / EBIT:
11.39x
EV / Revenue:
1.23x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
7.95x
Price / Operating cash flow:
5.66x
Enterprise value / EBITDA:
5.05x
Gross Profit (TTM):
$39.1M
Return On Assets:
14.68%
Net Income Margin (TTM):
9.8%
Return On Equity:
21.2%
Return On Invested Capital:
19.45%
Operating Margin:
11.65%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $121.2M $111M $114.3M $28.5M $31.1M
Gross Profit $34.4M $33.2M $39.1M $9.9M $10.8M
Operating Income -$1.7M $5.3M $12.4M $3.3M $3.6M
EBITDA $14.1M $22.6M $27.9M $7.2M $8.1M
Diluted EPS -$1.29 -$3.28 $0.04 -$0.04 $0.04
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $36.4M $29.7M $27.5M $22.7M $29.3M
Total Assets $142.5M $131.2M $125.9M $70.7M $90.6M
Current Liabilities $26.5M $24.6M $21.9M $21.9M $23.2M
Total Liabilities $45.5M $28.4M $37.8M $24.2M $32.8M
Total Equity $97.1M $102.8M $88.2M $46.5M $57.8M
Total Debt $15.6M $3.5M $15.3M $2.4M $8.6M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $17.8M $19.2M $25.1M $7.1M $7.4M
Cash From Investing -$12M -$7.4M -$23.5M -$1.7M -$17.7M
Cash From Financing -$4.9M -$15.6M $648K -$5.2M $4.9M
Free Cash Flow $5.8M $11.7M $17.7M $5.4M $5.7M
CCLD
Sector
Market Cap
$136.1M
$27.9M
Price % of 52-Week High
67.58%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
-0.12%
-1.49%
1-Year Price Total Return
-8.02%
-16.66%
Beta (5-Year)
1.945
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $3.24
200-day SMA
Buy
Level $2.56
Bollinger Bands (100)
Buy
Level 2.81 - 3.51
Chaikin Money Flow
Sell
Level -72.9M
20-day SMA
Buy
Level $3.13
Relative Strength Index (RSI14)
Buy
Level 53.52
ADX Line
Buy
Level 8.28
Williams %R
Neutral
Level -41.0256
50-day SMA
Buy
Level $3.14
MACD (12, 26)
Buy
Level 0.03
25-day Aroon Oscillator
Buy
Level 60
On Balance Volume
Neutral
Level 236.7M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.4172)
Buy
CA Score (Annual)
Level (1.1777)
Buy
Beneish M-Score (Annual)
Level (-4.0799)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-5.5328)
Buy
Piotroski F Score (Annual)
Level (9)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

CareCloud, Inc. is a healthcare information technology company, which engages in the provision of an integrated suite of proprietary cloud-based electronic health records and practice management solutions. It operates through the Healthcare IT and Practice Management segments. The Healthcare IT segment offers a proprietary web-based suite of services such as practice management applications, certified electronic health records solutions, revenue cycle management services and mobile health applications. The Practice Management segment provides medical practices as well as telemedicine, management, bill-paying and financial advisory services. The company was founded by Mahmud Haq in 1999 and is headquartered in Somerset, NJ.

Stock Forecast FAQ

In the current month, CCLD has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CCLD average analyst price target in the past 3 months is $6.31.

  • Where Will CareCloud, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that CareCloud, Inc. share price will rise to $6.31 per share over the next 12 months.

  • What Do Analysts Say About CareCloud, Inc.?

    Analysts are divided on their view about CareCloud, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CareCloud, Inc. is a Sell and believe this share price will drop from its current level to $3.25.

  • What Is CareCloud, Inc.'s Price Target?

    The price target for CareCloud, Inc. over the next 1-year time period is forecast to be $6.31 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is CCLD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for CareCloud, Inc. is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of CCLD?

    You can purchase shares of CareCloud, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CareCloud, Inc. shares.

  • What Is The CareCloud, Inc. Share Price Today?

    CareCloud, Inc. was last trading at $3.20 per share. This represents the most recent stock quote for CareCloud, Inc.. Yesterday, CareCloud, Inc. closed at $3.21 per share.

  • How To Buy CareCloud, Inc. Stock Online?

    In order to purchase CareCloud, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock